Purpose: To evaluate the outcome of treatment for high myopia by posterior phakic intraocular lens lens implantation
Setting: ophthalmology department, Sohag UniversityHospital, Sohag Faculty of Medicine. Methods: 23 eyes of 16 highly myopic patients were included in the study. The mean age was 25.4 years (range 18 to 35 years), the mean spherical equivalent (SE) -14.64 diopters (D) (range 8 to 28 D), , 23 eyes of 16 patients received posterior chamber phakic IOL (ICL) 10 females and 8 males the age ranges from (18-35 years). Results The spherical equivalent refraction at the last examination was within 1.0 D of the targeted refraction in 22 eyes (91.3% ) and within 0.5 D in 11 eyes (47.8%). Onecase ( 4.3%) complained of glare in the Ist week postoperative which improved, One case ( 4.3%) develpoed anterior subcapsular cataract after 1 year. Conclusion: Surgical management of high myopia byposterior chamber phakic IOL ( ICL) , is safe and predictable
Werblin TP: Why should refractive surgeons is looking beyond the cornea. J Refract Surg 1999, 15:359–376.
Sarver EJ, Sanders DR, Vukich JA: Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens. J Refract Surg 2003, 19:397–404.
Stephen S. Bylsma et al,Phakic posterior chamber intraocular lenspupillary block.J Cataract Refract Surg 2002; 28:2222–2228.
Laurent Kodjikian et al, Malignant glaucoma induced by a phakic posteriorchamber intraocular lens for myopia.J Cataract Refract Surg 2002; 28:2217–2221.
Zaldivar R, Davidorf JM, Oscherow S. Posterior chamberphakic intraocular lens for myopia of -8 to -19diopters. J Refract Surg 1998; 14:294–305.
Arne JL, Lesueur LC. Phakic posterior chamber lenses forhigh myopia: functional and anatomical outcomes. J CataractRefract Surg 2000; 26:369–374.
Michael W. Raciti • Parag A. Majmudar, Phakic IOLs: Sulcus Versus Iris-Claw Versus Angle-Supported: Complications and Outcomes:Curr Ophthalmol Rep (2013) 1:45–49.
Kohnen T, Kook D, Morral M, Gu¨ell JL. Phakic intraocular lenses: part 2: results and complications. J Cataract Refract Surg. 2010;36(12):2168–94.
Implantable Contact Lens in Treatment of Myopia in- (ITM) Study Group. United States Food and Drug Administration clinical trial of the implantable Collamer . Posterior lens (ICL) for moderate to high myopia; three-year follow-up. Ophthalmology 2004; 111:1683–1692.
Anna-Ulrika Sarikkola, et al, Traumatic cataract and other adverse events with the implantable contact lens: J Cataract Refract Surg 2005; 31:511–524.
Abd Ellah, M. (2017). The Outcome of Management of High Myopia by Intraocular Collamer Lens. Sohag Medical Journal, 21(3), 413-417. doi: 10.21608/smj.2017.41275
MLA
Marwa Mahmoud Abd Ellah. "The Outcome of Management of High Myopia by Intraocular Collamer Lens". Sohag Medical Journal, 21, 3, 2017, 413-417. doi: 10.21608/smj.2017.41275
HARVARD
Abd Ellah, M. (2017). 'The Outcome of Management of High Myopia by Intraocular Collamer Lens', Sohag Medical Journal, 21(3), pp. 413-417. doi: 10.21608/smj.2017.41275
VANCOUVER
Abd Ellah, M. The Outcome of Management of High Myopia by Intraocular Collamer Lens. Sohag Medical Journal, 2017; 21(3): 413-417. doi: 10.21608/smj.2017.41275